´ëÇѽÉÀåÇÐȸ (¿Â¶óÀÎ) 2021³â Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ : 2021-04-17±³À°ÀÏÀÚ : 2021-04-17
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) 2021³â Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
´ã´çÀÚ : Á¶À±ÇÏ
¿¬¶ôó : 02-3275-5258
À̸ÞÀÏ :
herz8@circulation.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
´ë±¸±¤¿ª½Ã±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 20,000¿ø
ºñ°í ±³¼ö ¹× °³¿øÀÇ: 20000¿ø/ÀüÀÓÀÇ, Àü°øÀÇ, ±âŸ: 10000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀÎ 09:00~09:20 What Is Clonal Hematopoiesis of Indeterminate Potential (CHIP)? S. Jaiswal(Stanford Univ. USA)
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀÎ 09:20~09:40 CHIP, A Common Risk Factor for Cardiology and Oncology °í¿µÀÏ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀÎ 09:40~10:00 CHIP and Atherosclerotic Cardiovascular Disease ÀÌÈñ¼±(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀÎ 10:00~10:20 How Will We Use CHIP in Clinical Practice? À̼±±â(ÇѸ²ÀÇ´ë)
Åä·Ð 04¿ù 17ÀÏ ¿Â¶óÀÎ 10:20~10:30 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)
ÈÞ½Ä 04¿ù 17ÀÏ 10:30~10:40 Break ()
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀÎ 10:40~11:00 Role of Myocardial Viability Imaging in Post-STICH Era: Interventionist Perspectives ¾ÈÁ¤¹Î(¿ï»êÀÇ´ë)
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀÎ 11:00~11:20 Viability Imaging: ECHO and Cardiologist Perspectives Á¶Àͼº(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀÎ 11:20~11:40 Myocardial Viability: MRI ¹Úöȯ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀÎ 11:40~12:00 Myocardial Viability: PET/SPECT Á¶»ó°Ç(Àü³²ÀÇ´ë)
Åä·Ð 04¿ù 17ÀÏ ¿Â¶óÀÎ 12:00~12:10 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)
ÈÞ½Ä 04¿ù 17ÀÏ 12:10~12:15 Break ()
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀÎ 12:15~12:35 Combination Therapy of Antihypertensive Drugs for Cardiovascular Protection ÃÖ¼ºÈÆ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀÎ 12:35~12:55 Why Should We Consider Strongly Rosuvastatin Ezetimibe Combination Therapy? ÇÑÁ¤±Ô(¼¿ïÀÇ´ë)
ÈÞ½Ä 04¿ù 17ÀÏ 12:55~13:10 Break ()
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀÎ 13:10~13:30 Diverse causes of pulmonary vein stenosis ±èÁö³ª(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀÎ 13:30~13:50 Diagnosis and medical management of pulmonary vein stenosis Á¤¼öÀÎ(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀÎ 13:50~14:10 Transcatheter treatment of pulmonary vein stenosis ±è±â¹ü(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀÎ 14:10~14:30 Best surgical strategy to prevent re-stenosis of pulmonary vein stenosis ¹Úõ¼ö(¿ï»êÀÇ´ë)
Åä·Ð 04¿ù 17ÀÏ ¿Â¶óÀÎ 14:30~14:40 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)
ÈÞ½Ä 04¿ù 17ÀÏ 14:40~14:50 Break ()
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀÎ 14:50~15:10 TAVR Valve Leaflet Thrombosis and a Role of CFD Analysis ÀÌ°ü¿ë(°¡Å縮ÀÇ´ë)
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀÎ 15:10~15:30 Hemodynamic Characteristics Around a Vulnerable Stenosis ÃÖ¿ì¶ô(POSTECH)
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀÎ 15:30~15:50 Deep Learning Models for Predicting Lung Diseases Such as COPD and COVID-19 ÃÖ»óÇå(°æºÏ´ëÇб³)
±³À°½Ã°£ 04¿ù 17ÀÏ ¿Â¶óÀÎ 15:50~16:10 Convolutional Neural Network Method for Classification of Heart Sounds À¯µ¿Çö(POSTECH)
Åä·Ð 04¿ù 17ÀÏ ¿Â¶óÀÎ 16:10~16:20 Discussion ´Ù°»ç(´Ù¼Ò¼Ó)